Aurinia to Merge With Kezar Life Sciences

Aurinia Pharma U.S., Inc. and Aurinia Merger Sub, Inc. entered an agreement and plan of merger with Kezar Life Sciences, Inc., dated March 30, 2026. The filing sets out the offer process and merger closing mechanics, including merger without a meeting of stockholders.

The agreement includes provisions for merger effects, treatment of equity awards, and a contingent value right. It also covers representations and warranties, covenants for conduct of business, and conditions precedent to the merger.